Literature DB >> 16913350

Course of vasopressin and copeptin plasma concentrations in a patient with severe septic shock.

S Jochberger1, G Luckner, V D Mayr, V Wenzel, N G Morgenthaler, B E Friesenecker, W R Hasibeder, M W Dünser.   

Abstract

In this case report, the course of arginine vasopressin and copeptin, the stable C-terminal part of the arginine vasopressin precursor, is described during the period of critical illness in a septic shock patient. Arginine vasopressin and copeptin concentrations were substantially increased during the initial 36 hours of shock. Subsequently, both hormones continuously decreased, but exhibited another peak in response to stress during extubation. During restoration of cardiovascular stability, endogenous arginine vasopressin levels further decreased and obviously did not contribute to haemodynamic improvement. In contrast, the decrease in arginine vasopressin and copeptin can be at least partly explained by an improvement of cardiovascular function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16913350     DOI: 10.1177/0310057X0603400415

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  7 in total

1.  Vasopressin in the pediatric cardiac intensive care unit: Myth or reality.

Authors:  Vishal K Singh; Rajesh Sharma; Amit Agrawal; Amit Varma
Journal:  Ann Pediatr Cardiol       Date:  2009-01

2.  Plasma levels of copeptin in patients with coronary heart disease.

Authors:  San Bao Chai; Yong Ming Hui; Xue Min Li; Yang Xiao; Chao Shu Tang
Journal:  Heart Vessels       Date:  2009-04-01       Impact factor: 2.037

Review 3.  A Dormant Microbial Component in the Development of Preeclampsia.

Authors:  Douglas B Kell; Louise C Kenny
Journal:  Front Med (Lausanne)       Date:  2016-11-29

4.  Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS).

Authors:  Kyeongman Jeon; Jae-Uk Song; Chi Ryang Chung; Jeong Hoon Yang; Gee Young Suh
Journal:  Crit Care       Date:  2018-05-21       Impact factor: 9.097

5.  Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia.

Authors:  Renato Seligman; Jana Papassotiriou; Nils G Morgenthaler; Michael Meisner; Paulo J Z Teixeira
Journal:  Crit Care       Date:  2008-02-02       Impact factor: 9.097

Review 6.  Copeptin and its potential role in diagnosis and prognosis of various diseases.

Authors:  Lidija Dobsa; Kido Cullen Edozien
Journal:  Biochem Med (Zagreb)       Date:  2013       Impact factor: 2.313

7.  Risk stratification in emergency patients by copeptin.

Authors:  Kasper Iversen; Jens P Gøtze; Morten Dalsgaard; Henrik Nielsen; Søren Boesgaard; Morten Bay; Vibeke Kirk; Olav W Nielsen; Lars Køber
Journal:  BMC Med       Date:  2014-05-16       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.